News & Updates

Show Multimedia Only
Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026 byNatalia Reoutova

A retrospective cohort study conducted in Hong Kong among adults with co-existing asthma and diabetes mellitus (DM) has found a lower risk of asthma exacerbation with glucagon-like peptide-1 receptor agonist (GLP-1 RA) vs dipeptidyl peptidase-4 inhibitor (DPP-4i) treatment.

Lower risk of asthma exacerbation with GLP-1 RA vs DPP-4i in patients with DM

17 Aug 2026
Once-a-week pill for HIV-1 a step closer to reality

Once-a-week pill for HIV-1 a step closer to reality

15 Aug 2026 byStephen Padilla

People living with HIV (PWH) may soon benefit from a once-weekly treatment regimen instead of the standard daily antiretroviral therapy to manage their condition. Two recent phase III trials, ISLEND-1 and -2, have shown the efficacy of islatravir/lenacapavir (ISL/LEN) vs bictegravir/emtricitabine/tenofovir/alafenamide (B/F/TAF) or standard of care (SOC).

Once-a-week pill for HIV-1 a step closer to reality

15 Aug 2026